About Hermas Biotech Private Limited
Data last updated:
Hermas Biotech Private Limited is a private limited company based in Bhiwandi, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 October 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2014PTC258834. Its GSTIN is 27AADCH5130N1ZG (Maharashtra).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Mushir Ahmad Sagir Ahmad Shaikh and Naim Ahmad Ishtiaque Ahmad Azmi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gala No 1 House No 97 Bandar Mohalla Thane Bhiwandi, Maharashtra, India – 421308.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.21 Cr. For the same year it recorded a net profit of ₹2.16 Lakh (net margin 1.8%) and EBITDA of ₹3.3 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hermasbiotech.co.in.
Company details
Contact details
Hermas Biotech Private Limited's registered office is in Bhiwandi, Maharashtra. Its website is hermasbiotech.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGala No 1 House No 97 Bandar Mohalla Thane Bhiwandi, Maharashtra, India – 421308
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hermas Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hermas Biotech is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Hermas Biotech Private Limited, buy the company report.
Financials of Hermas Biotech Private Limited
FY 2025 filings availableHermas Biotech Private Limited reported revenue of ₹1.21 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years. EBITDA fell 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hermas Biotech Private Limited, buy the company report.
Board of directors of Hermas Biotech Private Limited
Hermas Biotech has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mushir Ahmad Sagir Ahmad Shaikh | Director | 22 Oct 2014 | 12 Years 0 Months | Current |
| Naim Ahmad Ishtiaque Ahmad Azmi | Director | 22 Oct 2014 | 12 Years 0 Months | Current |
| Mohammed Qaiser Mohammed Ashhad | Director | 14 Mar 2016 | 10 Years 7 Months | Current |
Auditor
Hermas Biotech Private Limited is audited by MANCHEWAR & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANCHEWAR & ASSOCIATES | FY 2022 | 150862W |
Shareholding
The shareholding of Hermas Biotech Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hermas Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hermas Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hermas Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hermas Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCH5130N1ZG | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hermas Biotech Private Limited, buy the company report.
Recent activity
Hermas Biotech Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Mohammed Qaiser Mohammed Ashhad was appointed as Director on 14 Mar 2016.
Frequently asked questions
Hermas Biotech is an active private limited company based in Bhiwandi, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 October 2014 (12+ years old) and is registered under CIN U74120MH2014PTC258834.
Hermas Biotech has 3 current directors:
- Mushir Ahmad Sagir Ahmad Shaikh - Director
- Naim Ahmad Ishtiaque Ahmad Azmi - Director
- Mohammed Qaiser Mohammed Ashhad - Director
The latest financial statements of Hermas Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hermas Biotech is 27AADCH5130N1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Hermas Biotech is U74120MH2014PTC258834. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hermas Biotech was incorporated on 22 October 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Mohammed Qaiser Mohammed Ashhad was appointed as Director on 14 Mar 2016. Adeeb Shaikh Ahmad ceased to be Director on 26 Feb 2016. Mushir Ahmad Sagir Ahmad Shaikh was appointed as Director on 22 Oct 2014. Hermas Biotech has 4 board changes on record in total.
Hermas Biotech can be reached through the website hermasbiotech.co.in. Its registered office is in Bhiwandi, Maharashtra, India.
The registered office of Hermas Biotech is at Gala No 1 House No 97 Bandar Mohalla Thane Bhiwandi, Maharashtra, India – 421308.
Hermas Biotech operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
